Inhibitory Effect of IFN-, on the Antitumor Activity of Celecoxib in U87 Glioma Model |
Kim, Eun-Kyoung
(Department of Neurosurgery, The Catholic University of Korea College of Medicine, Kangnam St. Mary's Hospital)
Chung, Dong-Sup (Department of Neurosurgery, The Catholic University of Korea College of Medicine, Incheon St. Mary's Hospital) Shin, Hye-Jin (Department of Neurosurgery, The Catholic University of Korea College of Medicine, Kangnam St. Mary's Hospital) Hong, Yong-Kil (Department of Neurosurgery, The Catholic University of Korea College of Medicine, Kangnam St. Mary's Hospital) |
1 | Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK, et al. : Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60 : 4926-4931, 2000 ScienceOn |
2 | Juang SH, Wei SJ, Hung YM, Hsu CY, Yang DM, Liu KJ, et al. : IFNbeta induces caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell lines. J Interferon Cytokine Res 24 : 231-243, 2004 DOI ScienceOn |
3 | Mathieu V, De Nve N, Le Mercier M, Dewelle J, Gaussin JF, Dehoux M, et al. : Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model. Neoplasia 10 : 1383-1392, 2008 DOI ScienceOn |
4 | Taketo MM : Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J Natl Cancer Inst 90 : 1609-1620, 1998 DOI |
5 | Natsume A, Mizuno M, Ryuke Y, Yoshida J : Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse. Gene Ther 6 : 1626-1633, 1999 DOI ScienceOn |
6 | Prayson RA, Castilla EA, Vogelbaum MA, Barnett GH : Cyclooxygenase-2 (COX-2) expression by immunohistochemistry in glioblastoma multiforme. Ann Diagn Pathol 6 : 148-153, 2002 DOI ScienceOn |
7 | Chan JL, Lee SW, Fraass BA, Normolle DP, Greenberg HS, Junck LR, et al. : Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 20 : 1635-1642, 2002 DOI ScienceOn |
8 | Dong Z, Greene G, Pettaway C, Dinney CP, Eue I, Lu W, et al. : Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta. Cancer Res 59 : 872-879, 1999 ScienceOn |
9 | Thomas H, Balkwill FR : Effects of interferons and other cytokines on tumors in animals : a review. Pharmacol Ther 52 : 307-330, 1991 DOI ScienceOn |
10 | Peres E, Wood GW, Poulik J, Baynes R, Sood S, Abidi MH, et al. : High-dose chemotherapy and adoptive immunotherapy in the treatment of recurrent pediatric brain tumors. Neuropediatrics 39 : 151-156, 2008 DOI ScienceOn |
11 | Krown SE : Interferons in malignancy : biological products or biological response modifiers? J Natl Cancer Inst 80 : 306-309, 1998 |
12 | Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF : Cyclooxygenase-2 expression in human gliomas : prognostic significance and molecular correlations. Cancer Res 61 : 4375-4381, 2001 |
13 | Taketo MM : Cyclooxygenase-2 inhibitors in tumorigenesis (Part I). J Natl Cancer Inst 90 : 1529-1536, 1998 DOI ScienceOn |
14 | Nakamoto N, Higuchi H, Kanamori H, Kurita S, Tada S, Takaishi H, et al. : Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo. Int J Oncol 29 : 625-635, 2006 |
15 | Nam DH, Park K, Park C, Im YH, Kim MH, Lee S, et al. : Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib. Oncol Rep 11 : 263-268, 2004 |
16 | Wei D, Wang L, He Y, Xiong HQ, Abbruzzese JL, Xie K : Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res 64 : 2030-2038, 2004 DOI ScienceOn |
17 | Deininger MH, Meyermann R, Trautmann K, Morgalla M, Duffner F, Grote EH, et al. : Cyclooxygenase (COX)-1 expressing macrophages/microglial cells and COX-2 expressing astrocytes accumulate during oligodendroglioma progression. Brain Res 885 : 111-116, 2000 DOI ScienceOn |
18 | Huang SF, Kim SJ, Lee AT, Karashima T, Bucana C, Kedar D, et al. : Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel. Cancer Res 62 : 5720-5726, 2002 ScienceOn |
19 | Park JA, Joe YA, Kim TG, Hong YK : Potentiation of antiglioma effect with combined temozolomide and interferon-beta. Oncol Rep 16 : 1253-1260, 2006 |
20 | Lee J, Jung HH, Im YH, Kim JH, Park JO, Kim K, et al. : Interferon-alpha resistance can be reversed by inhibition of IFN-alphainduced COX-2 expression potentially via STAT1 activation in A549 cells. Oncol Rep 15 : 1541-1549, 2006 |
21 | Hong YK, Chung DS, Joe YA, Yang YJ, Kim KM, Park YS, et al. : Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development. Clin Cancer Res 6 : 3354-3360, 2000 ScienceOn |
22 | Cao B, Chen XP, Zhu P, Ding L, Guan J, Shi ZL : Inhibitory effect of interferon--2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice. World J Gastroenterol 14 : 6802-6807, 2008 DOI ScienceOn |
23 | Chiu HW, Ho SY, Guo HR, Wang YJ : Combination treatment with arsenic trioxide and irradiation enhances autophagic effects in U118-MG cells through increased mitotic arrest and regulation of PI3K/Akt and ERK1/2 signaling pathways. Autophagy 5 : 472-483, 2009 DOI ScienceOn |
24 | Kardosh A, Blumenthal M, Wang WJ, Chen TC, Schnthal AH : Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines. Cancer Biol Ther 3 : 55-62, 2004 ScienceOn |
25 | Kornblith PK, Welch WC, Bradley MK : The future of therapy for glioblastoma. Surg Neurol 39 : 538-543, 1993 DOI ScienceOn |
26 | Cao Y, Prescott SM : Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 190 : 279-286, 2002 DOI ScienceOn |
27 | Ma Z, Qin H, Benveniste EN : Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta : critical role of STAT-1alpha. J Immunol 167 : 5150-5159, 2001 DOI |
28 | Ohno M, Natsume A, Fujii M, Ito M, Wakabayashi T : Interferonbeta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma. Pediatr Blood Cancer 53 : 37-41, 2009 DOI ScienceOn |
29 | Ruggiero A, Cefalo G, Garré ML, Massimino M, Colosimo C, Attin G, et al. : Phase II trial of temozolomide in children with recurrent high-grade glioma. J Neurooncol 77 : 89-94, 2006 DOI ScienceOn |